Gainers
- Enochian BioSciences ENOB stock increased by 147.84% to $10.93 during Monday's pre-market session. The company's market cap stands at $522.4 million.
- ITeos Therapeutics ITOS stock moved upwards by 51.27% to $30.3. The company's market cap stands at $1.0 billion.
- Entasis Therapeutics Hldg ETTX stock rose 24.25% to $3.33. The market value of their outstanding shares is at $136.6 million.
- Eyegate Pharmaceuticals EYEG shares rose 22.49% to $5.5. The company's market cap stands at $39.0 million.
- Xenetic Biosciences XBIO shares increased by 15.9% to $2.55. The market value of their outstanding shares is at $22.3 million.
- Mereo BioPharma Group MREO stock increased by 12.57% to $3.58. The company's market cap stands at $387.5 million.
Losers
- Avenue Therapeutics ATXI shares declined by 44.42% to $2.34 during Monday's pre-market session. The market value of their outstanding shares is at $39.1 million.
- Fortress Biotech FBIO stock decreased by 13.15% to $3.9. The company's market cap stands at $379.5 million.
- Venus Concept VERO shares fell 6.64% to $2.25. The market value of their outstanding shares is at $121.6 million.
- ProPhase Labs PRPH shares declined by 6.1% to $6.01. The market value of their outstanding shares is at $91.0 million.
- Addex Therapeutics ADXN shares declined by 5.34% to $10.65. The market value of their outstanding shares is at $77.3 million.
- Koninklijke Philips PHG shares declined by 4.89% to $53.74. The company's market cap stands at $48.2 billion.
ATXIAvenue Therapeutics Inc
$1.794.07%
EYEGAB Corporate Bond ETF
--%
FBIOFortress Biotech Inc
$1.80-0.55%
ITOSITeos Therapeutics Inc
$7.30-2.28%
MREOMereo BioPharma Group PLC
$3.74-1.84%
PHGKoninklijke Philips NV
$25.41-0.27%
PRPHProPhase Labs Inc
$0.66523.47%
VEROVenus Concept Inc
$0.37293.58%
XBIOXenetic Biosciences Inc
$3.93-5.30%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in